An Open-Label Pilot Prospective Vulvoscopy With Photography Study of the Visible Changes in the Vulva, Vestibule and Vagina Pre- and Post- Twenty Weeks of Daily Administration of 60 Mg Ospemifene in Post-Menopausal Women With Dyspareunia From Vulvar Vaginal Atrophy

Trial Profile

An Open-Label Pilot Prospective Vulvoscopy With Photography Study of the Visible Changes in the Vulva, Vestibule and Vagina Pre- and Post- Twenty Weeks of Daily Administration of 60 Mg Ospemifene in Post-Menopausal Women With Dyspareunia From Vulvar Vaginal Atrophy

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Ospemifene (Primary)
  • Indications Dyspareunia; Vulval disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 29 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top